
GE HealthCare Technologies Inc. – NASDAQ:GEHC
GE HealthCare Technologies stock price today
GE HealthCare Technologies stock price monthly change
GE HealthCare Technologies stock price quarterly change
GE HealthCare Technologies stock price yearly change
GE HealthCare Technologies key metrics
Market Cap | 35.63B |
Enterprise value | 43.50B |
P/E | 21.68 |
EV/Sales | 2.22 |
EV/EBITDA | 12.16 |
Price/Sales | 1.85 |
Price/Book | 4.36 |
PEG ratio | 0.62 |
EPS | 3.44 |
Revenue | 19.49B |
EBITDA | 3.31B |
Income | 1.57B |
Revenue Q/Q | -1.21% |
Revenue Y/Y | 4.22% |
Profit margin | 8.57% |
Oper. margin | 13.14% |
Gross margin | 41.3% |
EBIT margin | 13.14% |
EBITDA margin | 17.01% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeGE HealthCare Technologies stock price history
GE HealthCare Technologies stock forecast
GE HealthCare Technologies financial statements
$92
Potential upside: 24.15%
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 4.81B | 418M | 8.68% |
---|---|---|---|
Sep 2023 | 4.82B | 375M | 7.78% |
Dec 2023 | 5.20B | 403M | 7.74% |
Mar 2024 | 4.65B | 374M | 8.04% |
2023-10-31 | 0.9 | 0.99 |
---|---|---|
2024-02-06 | 1.07 | 1.18 |
2024-04-30 | 0.91 | 0.9 |
Payout ratio | 3.22% |
---|
2019 | |
---|---|
2020 | |
2021 | |
2022 | |
2023 | 0.12% |
Jun 2023 | 32311000000 | 24.98B | 77.34% |
---|---|---|---|
Sep 2023 | 32382000000 | 25.24B | 77.94% |
Dec 2023 | 32454000000 | 25.14B | 77.48% |
Mar 2024 | 32208000000 | 24.60B | 76.41% |
Jun 2023 | -67M | -84M | -227M |
---|---|---|---|
Sep 2023 | 650M | -120M | -24M |
Dec 2023 | 1.05B | -88M | -900M |
Mar 2024 | 419M | -188M | -153M |
GE HealthCare Technologies alternative data
Aug 2023 | 50,000 |
---|---|
Sep 2023 | 50,000 |
Oct 2023 | 50,000 |
Nov 2023 | 50,000 |
Dec 2023 | 50,000 |
Jan 2024 | 50,000 |
Feb 2024 | 50,000 |
Mar 2024 | 51,000 |
Apr 2024 | 51,000 |
May 2024 | 51,000 |
Jun 2024 | 51,000 |
Jul 2024 | 51,000 |
GE HealthCare Technologies other data
Period | Buy | Sel |
---|---|---|
Jun 2023 | 0 | 2473 |
Jul 2023 | 0 | 15609 |
May 2024 | 1315 | 90482 |
Quarter | Transcript |
---|---|
Q1 2024 30 Apr 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 6 Feb 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 3 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 25 Jul 2023 | Q2 2023 Earnings Call Transcript |
GE HealthCare: Near-Term Margin Headwinds Priced In, Long-Term Growth Driven By New Products And M&As
GE HealthCare: The Demand Is Just Too Strong To Ignore
GE HealthCare: Looking Healthier Here
IRadimed Corporation: Steady, Low-Risk Grower In The Devices Space
2025 Could Be GE HealthCare's Year With Emphasis On Efficiency And AI Broadens
GE HealthCare: Near-Term Risks, But Some Interesting Longer-Term Opportunities
Siemens Healthineers: Softer Orders A Risk, But The Story Remains Sound
GE Vernova: Margin Expansion As Power Demand Ramps Up
GE HealthCare: A Good Buy At Current Levels
-
What's the price of GE HealthCare Technologies stock today?
One share of GE HealthCare Technologies stock can currently be purchased for approximately $74.1.
-
When is GE HealthCare Technologies's next earnings date?
Unfortunately, GE HealthCare Technologies's (GEHC) next earnings date is currently unknown.
-
Does GE HealthCare Technologies pay dividends?
Yes, GE HealthCare Technologies pays dividends and its trailing 12-month yield is 0.19% with 3% payout ratio. The last GE HealthCare Technologies stock dividend of undefined was paid on 6 Sep 2025.
-
How much money does GE HealthCare Technologies make?
GE HealthCare Technologies has a market capitalization of 35.63B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 6.6% to 19.55B US dollars. GE HealthCare Technologies earned 1.57B US dollars in net income (profit) last year or $0.9 on an earnings per share basis.
-
What is GE HealthCare Technologies's stock symbol?
GE HealthCare Technologies Inc. is traded on the NASDAQ under the ticker symbol "GEHC".
-
What is GE HealthCare Technologies's primary industry?
Company operates in the Healthcare sector and Medical - Healthcare Information Services industry.
-
How do i buy shares of GE HealthCare Technologies?
Shares of GE HealthCare Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does GE HealthCare Technologies have?
As Jul 2024, GE HealthCare Technologies employs 51,000 workers.
-
When GE HealthCare Technologies went public?
GE HealthCare Technologies Inc. is publicly traded company for more then 2 years since IPO on 15 Dec 2022.
-
What is GE HealthCare Technologies's official website?
The official website for GE HealthCare Technologies is gehealthcare.com.
-
Where are GE HealthCare Technologies's headquarters?
GE HealthCare Technologies is headquartered at 500 West Monroe Street, Chicago, IL.
-
How can i contact GE HealthCare Technologies?
GE HealthCare Technologies's mailing address is 500 West Monroe Street, Chicago, IL and company can be reached via phone at +61 74433400.
-
What is GE HealthCare Technologies stock forecast & price target?
Based on 4 Wall Street analysts` predicted price targets for GE HealthCare Technologies in the last 12 months, the avarage price target is $92. The average price target represents a 24.15% change from the last price of $74.1.
GE HealthCare Technologies company profile:

GE HealthCare Technologies Inc.
gehealthcare.comNASDAQ
51,000
Medical - Healthcare Information Services
Healthcare
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Chicago, IL 60661
CIK: 0001932393
ISIN: US36266G1076
CUSIP: 36266G107